Research programme: vascular endothelial growth factor inhibitors - Betta Pharma
Alternative Names: BP 702001; BP 703010Latest Information Update: 16 Jul 2016
At a glance
- Originator Zhejiang Betta Pharma
- Class
- Mechanism of Action Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in China
- 07 Jul 2009 Preclinical trials in Cancer in China (unspecified route)